Project Data Sphere Rewrites The Rules For Open Access Research On Cancer
Executive Summary
Now that Project Data Sphere has established itself as a world-class data sharing platform, the group’s leadership is planning for its next phase of the struggle against cancer. Project Data Sphere's president Bill Louv talks to In Vivo about how the group has "raised the bar on what is possible to achieve in cancer research."
You may also be interested in...
Point Man On Protein Science
In this latest edition of the Lab Links series on notable figures responsible for major advances in drug discovery, In Vivo talks to Harvard Medical School professor and biologist Timothy Springer on his 50-year record as an academic scientist, business entrepreneur and philanthropist. His latest venture is being co-founder – and principal funder – of the independent non-profit Institute for Protein Innovation, an institution designed to fill a critical niche in open-source biomedical research.
Can Bespoke Analytics Put A New Dazzle On Generics?
Disruptions in the supply/demand configuration of generic drugs have plagued US health care for years. Picket Pharmaceuticals, a new start-up founded by a biostatistician veteran of Africa’s war on HIV, is using the illuminating powers of big data to stabilize the generics supply chain and find untapped areas of value among thousands of products in a business that remains a mystery to physicians, payers and patients alike.
Can Bespoke Analytics Put New Dazzle On Copy Drugs?
Disruptions in the supply/demand configuration of generic drugs have plagued US health care for years. Picket Pharmaceuticals, a new start-up founded by a biostatistician veteran of Africa’s war on HIV, is using the illuminating powers of big data to stabilize the generics supply chain and find untapped areas of value among thousands of products in a business that remains a mystery to physicians, payers and patients alike.
Need a specific report? 1000+ reports available Buy Reports